when applied routinely to certain subgroups such as elderly patients,30,3' who often have heavily calcified valves or other associated valvular or ischemic heart disease. [32] [33] [34] To address these issues, the National Heart, Lung, and Blood Institute (NHLBI) proposed a multicenter Balloon Valvuloplasty Registry (BVR) to observe the results of balloon mitral commissurotomy and aortic balloon valvuloplasty in adult patients. In 24 centers, investigators prospectively registered all balloon valvuloplasty procedures attempted in their adult patients over a 2-year period. Baseline, immediate results, and up to 4-year follow-up data are reported to the BVR Coordinating Center at the University of Washington in Seattle. This report describes the immediate and 30-day clinical outcome for 738 consecutive patients undergoing balloon commissurotomy treatment of the native mitral valve. A detailed analysis of the technical aspects of the procedure-related complications and the associated morbidity is being reported separately. 35 
Methods
The purpose of the NHLBI BVR is to document the clinical practice of balloon mitral commissurotomy, including the technique and the immediate and long-term clinical results in adult patients. The BVR is a cooperative multicenter registry.
All patients aged 18 years or older who gave informed consent and had balloon mitral commissurotomy treatment of the native mitral valve initiated in the participating center between November 1, 1987, and October 31, 1989, were enrolled in the registry. Each enrolled patient was assigned a sequential identification number at each center. Protocol and procedure data and clinical and hemodynamic outcome in the 738 consecutive patients with balloon commissurotomy of the native mitral valve are reported here.
Each patient's history was recorded, and preprocedure clinical characteristics were evaluated. Congestive heart failure was graded according to New York Heart Association (NYHA) functional classification,36 and angina pectoris was graded by the Canadian Cardiovascular Society criteria. 37 The reasons for selecting balloon mitral commissurotomy treatment instead of surgery were recorded. The investigator identified major factors such as comorbid conditions, which doubled the perceived normal surgical risk, and minor factors, which influenced the clinical decision. Other reasons aside from surgical risk (such as patient or physician preference) that also influenced the clinical decision were recorded. None of these categories were mutually exclusive. When formal surgical consultations were available, their recommendations were recorded. The participating institutions' policies varied widely regarding routine surgical consultations before balloon mitral commissurotomy.
Baseline laboratory and procedure data were collected on each patient, including hematology and blood chemistry profile, previous catheterization data within 3 months of entry, echo Doppler studies before and 24-72 hours after the procedure, and hemodynamic data immediately before and after the procedure. The size and number of inflations of the polyethylene single-or double-balloon catheters (Mansfield Scientific, Cook, USCI) used for the procedure were recorded. The latex single-balloon catheters19 were unavailable during the enrollment period and were not used in our patients. Reasons for incomplete procedures, in which the balloon could not be positioned or inflated across the mitral valve, were recorded. Major complications were defined as emergency cardiac surgery, cardiac perforation, cardiac tamponade, acute mitral regurgitation, cerebrovascular accident, embolic event, pulmonary edema, cardiogenic shock, death, myocardial infarction, and pulmonary embolus. Although overall complication rates are noted for completeness in this report, a detailed analysis of complications for all patients is reported separately. 35 The patient's overall and cardiac clinical conditions at hospital discharge were recorded, and the 30-day clinical status was obtained by questionnaire at 5 weeks. Echocardiography
The baseline echocardiogram was performed within 30 days before the procedure (mean interval, 6.9 + 17.9 days) and the postcommissurotomy study was performed 24-72 hours after the procedure (mean interval, 35 .7+16.1 hours). Paired preprocedure and postprocedure recordings were available in 602 of the 738 enrolled patients (82%). Echocardiograms were not obtained in 50 patients (7%) after the procedure due to incomplete procedures.
The mitral stenosis jet was recorded from an apical approach, using either continuous-wave, conventional pulsed, or high pulse repetition frequency Doppler. Care was taken to obtain a tonal signal with a smooth velocity envelope of flow in diastole and a well-defined early diastolic peak velocity and slope.
The mean gradient38'39 was derived by integration of instantaneous pressure gradients throughout diastole (using either the measurement package on the instrument or an off-line system) averaged from three to five consecutive beats in sinus rhythm and five to 10 consecutive beats in atrial fibrillation. The mitral valve area by the pressure half-time method38-41 was averaged from three to five good-quality beats. Mitral regurgitation was assessed in at least two tomographic planes using conventional pulsed Doppler in 284 patients (41%), color flow imaging in 233 patients (34%), or both in 168 patients (25%). Mitral regurgitation was graded none, mild, moderate, or severe. 42 The cross-sectional area of the mitral orifice was determined from short-axis views obtained by scanning from the left ventricular apex slowly up to the mitral valve to determine the minimum orifice area. 43 Care was taken to set the gain at a minimal level and to trace the inner edge of echoes to directly measure the mitral orifice in centimeters squared. had severe stenosis, no regurgitation, or mild regurgitation and normal or unknown ventricular function. Laboratory baseline evaluation demonstrated creatinine greater than 1.2 mg% in 20% and hematocrit less than 35% in 11% of the patients. The cardiac rhythm was sinus in 52% and atrial fibrillation or flutter in 45%; a conduction defect was present in 18% of patients.
Medications included digitalis in 68% of patients, diuretics in 70%, calcium entry blocker in 12%, ,B-blockers in 16%, antiarrhythmics in 17%, and nitrates in 9%. Figure 1 summarizes the baseline assessment by the investigator of the presence and severity of valvular lesions in the patients. This assessment was based on clinical, echo Doppler, and cardiac catheterization data. Of the 736 patients who were assessed, all except two had moderate or severe mitral stenosis, and only 10% had moderate or severe mitral regurgitation. Less than 10% of the patients had moderate-to-severe aortic valve disease, and 9% had significant tricuspid regurgitation. There were 13 patients who had prosthetic aortic valves.
Mitral valve calcification as assessed on cinefluoroscopy was moderate to severe in 170 patients (24%). By echo Doppler assessment, aortic valve regurgitation was moderate to severe in 67 patients (10%), mitral valve regurgitation was moderate to severe in 109 patients (15%), and left ventricular systolic function was moderately to severely reduced in 26 patients (4%). Hemodynamic results were also compared for single-versus double-balloon procedures in the subgroups of patients without atrial septal defects and without significant mitral regurgitation (0 or 1+) before and after the procedure. In patients without atrial septal defects, the mean mitral valve area after double-balloon procedures (2.0±0.8 cm2) was signif- 
Factors Affecting Hemodynamic Results
In addition to single-versus double-balloon techniques, other factors potentially affecting the immediate hemodynamic outcome were analyzed. Figure 3 shows the relation between the increases in mitral valve areas determined by cardiac catheterization and mitral valve morphology assessed by echocardiographic scores. In 11 patients (2%), the etiology of the mitral stenosis was calcific and the valve morphology was not scored. When echo score was treated as a continuous variable, the increases in mitral valve area were only weakly related to echo score (r= -0.15). When echo score was treated as a dichotomous variable, patients with the lower echo scores (scores of 4-8) had slightly greater mean increases in mitral valve area (1.0±0.7 cm2) compared with patients with the higher scores of 9-16 (0.85+0.6 cm2,p=0.004).
The final mitral valve areas were greater than or equal to 1.5 When categorical variables were used for univariate analysis, several important predictors were also identified. Table 5 shows the number (and percentage) of patients in each category who demonstrated improved clinical status at 30-day follow-up. Improvement rates are higher in patients who are treated with double-balloon techniques, who have normal baseline ECGs, and are less symptomatic before the procedure. Experience of the center also influenced immediate outcome. Patients who are treated in higher-volume centers or later in an individual institution's experience (higher patient sequence number) are also more frequently improved at 30 days. However, improvement rates are similar in each of the 2 years of enrollment in the registry, suggesting that the learning curve for this procedure is rather steep.
Multivariate analysis was also performed to identify independent baseline characteristics that could distinguish the patients who improved from the patients who did not. However, because relatively few patients did not show improvement at 30 days, the logistic regression model was unable to accurately classify these patients (specificity, 8.5%). By stepwise logistic regression, baseline mitral valve area greater than 0.5 cm2 (odds ratio, 3.0; 95% CI, 1.5-6.0; p =0.002), age less than 70 years (odds ratio, 2.1; 95% CI, 1.2-3.5;p=0.008), and higher case volume of the center (odds ratio, 2.0; 95% CI, 1.5-2.6;p<0.0001), were identified as independent risk factors for improved clinical status.
Analysis of Clinical Outcome for Completed Procedures
In addition to reporting the technical and procedure results, it is important to document the reasons for incomplete procedures and the expected clinical outcome of patients who have completed procedures, that is, those patients who had one or two balloons inflated across the mitral valve. Procedures were not completed in 58 patients (8% of all patients) due to failure to reach the valve in 13 patients (22%), failure to cross the valve in five patients (9%), complications in 26 patients (45%), or other causes in 14 patients (24%).
In our diverse group of patients, 92% of the balloon procedures (680 cases) were completed. In the 680 patients, there were major complications in 8% and mortality in the laboratory in three patients (<1%). The mean hospital stay was 3.6±6.8 days after the procedure. At discharge from hospital, 73% improved, 25% were stable, <1% were worse, and 2% died. Referral for mitral valve surgery at 30 days occurred in 25 of 626 patients (4%). At 30-day follow-up (n=562), 85% of the patients had improved their overall condition; 9% were stable. Six percent were worse, and the total mortality was 16 of 641 patients (3%). The cardiac condition showed improved NYHA functional class in 85% of patients, and 62% were in functional class I.
Analysis of Clinical Outcome by Complexity of Valve Disease
An important question regarding referral of a patient for balloon mitral commissurotomy is the potential impact of complex valvular heart disease on the expected clinical improvement in that patient. In Table 6 , the 681 patients with all valves assessed are grouped according to the presence of other moderate or severe valve disease. Valve assessment was not available for 57 patients. Patients with isolated mitral stenosis are compared with those with combined mitral stenosis and moderate or severe mitral regurgitation, and a third group with moderate or severe multivalvular disease.
As shown in Table 6 , patients with complex valve disease were older than the mitral stenosis-only group of patients, and more patients with complex disease were in functional class III or IV. There were significant increases in mitral valve areas in all groups after balloon mitral commissurotomy, al- 30 days were baseline mitral valve area >0.5 cm2, age less than 70 years, and procedure performed in higher-volume centers. Analysis of the 30-day outcome in the subgroup of patients with completed procedures showed that NYHA functional class improved in 85% of patients, 4% were referred for surgery, and there was a 3% mortality rate. Analysis of the 30-day outcome for patients with multiple valve lesions showed that patients with mixed mitral stenosis and regurgitation had outcomes similar to those with isolated mitral stenosis. Patients with multivalve disease also showed improved hemodynamics and had similar in-hospital course and similar 30-day survival and surgery rates, but fewer achieved asymptomatic cardiac status.
The immediate results in our patients may not be directly comparable to other series of patients from single institutions because of the large range in numbers of patients reported and variations in clinical characteristics and patient selection criteria between these studies. Reported series have included from 22 to 200 patients.27-29,44,47-51 The mean ages of the patients ranged from 26 to 59 years. Thirty percent to 100% of the patients were in sinus rhythm, and 33-90% were in NYHA functional class III or IV. Fluoroscopic mitral valve calcification was present in 10-35%, whereas comorbid medical conditions and coexisting moderate or severe lesions in other valves were rare. These series reported successful completion of 79-100% of the procedures and incurred procedure-related mortalities of 0-4%. Some increase in mitral regurgitation was noted in 4-50%, and interatrial shunt flow after the procedures was documented in 0-22% of the patients. The mean mitral valve areas ranged from 0.8 to 1.2 cm2 before the procedure and increased up to 1.6-2.3 cm2 immediately after the procedure. Most of these patients noted improved clinical status at discharge from the hospital.
These previous studies also used various techniques including both single and double balloons,27-29,4748 single nylon-rubber balloons,49,50 and retrograde transarterial5l approaches. In our study, the results of single and double polyethylene balloons are directly compared. The larger Inoue balloon was not used in these registry patients. The double-balloon procedure was used in 84% of our patients, and 97% of these procedures were completed. Our catheterization and echo Doppler data show that the doubleballoon procedures resulted in wider opening of the mitral valve orifices. Patients treated with single-and double-balloon procedures had a similar incidence of increased mitral regurgitation, but patients treated with double balloons had a higher incidence of interatrial shunts documented by oximetry.
Potential sources of error exist in measuring mitral valve area, especially after valvotomy by the pressure half-time, Gorlin, and two-dimensional echocardiographic planimetry methods. Pressure half-time may underestimate planimetric determinations because of changes in peak left atrial pressure and atrial compliance.52 '53 [31] [32] [33] However, the long-term effects of combined aortic and mitral balloon treatment is likely to be limited by the small improvements in aortic valve function expected in these patients. 68 In contrast, in reported patients undergoing multiple valve surgery, the 10-18% operative mortality69'70 has recently been considerably reduced using modern myocardial preservation techniques. 71 Although balloon mitral commissurotomy remains an investigational procedure, several studies, including the present one, have shown that it is an effective therapeutic alternative for patients with symptomatic mitral valve stenosis. Patients likely to benefit most from this procedure are patients who have pliable valves and are also good surgical candidates. Patients with calcified or immobile valves who might benefit less or have higher risks during balloon mitral commissurotomy are those patients who would likely undergo mitral valve replacement, which also carries higher perioperative risks. Access to an experienced center and the physician and patient preference also contributed to the choice of treatment in our patients. Long-term follow-up studies of these registry patients will be necessary to further evaluate the clinical efficacy of balloon mitral commissurotomy.
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